SV Biotech Crossover Opportunities Fund LP
- Fund Information and Directors
| SV Biotech Crossover Opportunities Fund LP |
| Firm |
SV Health Managers LLP
|
| Fund # | 805-7518985019 |
| CIK # | 0001903934 |
| Sale | 2021-12-31
($350.0 M Offered, $135.2 M Sold)
|
| Fund | Venture Capital Fund |
| Phone | 442074217081 |
| Address | 71 Kingsway
London, United Kingdom WC2B 6ST |
| Source |
[EDGAR]
[IAPD]
|
| Fund AUM and Sold ($M) |
|
|
| Fund Details |
| Director | SV BCO I GP LLP |
| Custodian | Morgan Stanley Smith Barney LLC, Computershare Investor Services LLC, Barclays Banks UK PLC, Aztec Financial Services UK Limited, Barclays Bank PLC |
| Auditor | RSM UK Audit LLP, Pricewaterhouse Coopers LLP |
| Marketer | Private Capital Advisors Ltd, Volten Asset Management Ltd |
| Broker | |
| Jurisdiction | |
| Form D Offering |
| Filed | 2022-01-18 (D) |
| Exemption | 506(b), 3(c), 3(c)(7) |
| Remaining | $214,820,000 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 212252935, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
315704680